Tempest Therapeutics Inc (TPST)

Jan 09, 2026

Tempest Therapeutics Faces Nasdaq Noncompliance, Plans Annual Meeting - TipRanks

Jan 09, 2026

Jan 09, 2026

Tempest Therapeutics receives Nasdaq notice for annual meeting compliance - Investing.com

Jan 09, 2026

Jan 09, 2026

Tempest Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets

Jan 09, 2026

Jan 09, 2026

Why retail investors favor Tempest Therapeutics Inc. stockJuly 2025 Chart Watch & High Win Rate Trade Tips - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

Will Tempest Therapeutics Inc. stock pay special dividendsJuly 2025 Outlook & Risk Controlled Stock Pick Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Will Tempest Therapeutics Inc. stock split again soonJuly 2025 Update & Fast Momentum Stock Entry Tips - ulpravda.ru

Jan 08, 2026

Dec 30, 2025

Tempest Therapeutics, Inc.Common Stock (NQ: TPST - FinancialContent

Dec 30, 2025

Dec 29, 2025

Market Outlook: Will Tempest Therapeutics Inc stock pay special dividendsJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - moha.gov.vn

Dec 29, 2025

Dec 26, 2025

Tempest Therapeutics (TPST) Stock Price, Quote, News & History - Benzinga

Dec 26, 2025

Dec 22, 2025

Will Tempest Therapeutics Inc. stock beat EPS estimatesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - bolumsonucanavari.com

Dec 22, 2025

Dec 19, 2025

How sustainable is Tempest Therapeutics Inc. stock dividend payout2025 Winners & Losers & Verified Momentum Stock Alerts - Улправда

Dec 19, 2025

Nov 27, 2025

Tempest Therapeutics closes $4.25 million registered direct offering By Investing.com - Investing.com India

Nov 27, 2025

Nov 26, 2025

Tempest Therapeutics Closes $4.3 Million Direct Offering - MarketScreener

Nov 26, 2025

Nov 26, 2025

Tempest Therapeutics closes $4.25 million registered direct offering - Investing.com

Nov 26, 2025

Nov 26, 2025

Tempest Therapeutics : Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules - MarketScreener

Nov 26, 2025

Nov 26, 2025

Tempest Therapeutics, Inc. Completes Registered Direct Offering and Private Placement, Raising Approximately $4.25 Million - Quiver Quantitative

Nov 26, 2025

Nov 26, 2025

Tempest Announces Closing of Up To $8.35 Million Registered - GlobeNewswire

Nov 26, 2025

Nov 26, 2025

[8-K] Tempest Therapeutics, Inc. Reports Material Event | TPST SEC FilingForm 8-K - Stock Titan

Nov 26, 2025

Nov 25, 2025

Form 8-KCurrent report - ADVFN

Nov 25, 2025

Nov 25, 2025

Tempest Therapeutics stock falls after $4.25 million direct offering - MSN

Nov 25, 2025

Nov 25, 2025

[424B5] Tempest Therapeutics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan

Nov 25, 2025

Nov 25, 2025

Form 424B5 Tempest Therapeutics, - StreetInsider

Nov 25, 2025

Nov 25, 2025

Tempest Therapeutics stock falls after $4.25 million direct offering By Investing.com - Investing.com UK

Nov 25, 2025

Nov 25, 2025

Tempest Therapeutics raises $4.25 million in registered direct offering - Investing.com

Nov 25, 2025

Nov 25, 2025

Tempest Therapeutics Inc (TPST) Performance and Fundamentals Dashboard tells a completely different story - setenews.com

Nov 25, 2025

Nov 25, 2025

Tempest Therapeutics raises $4.25 million in registered direct offering By Investing.com - Investing.com India

Nov 25, 2025

Nov 25, 2025

Tempest Therapeutics (Nasdaq: TPST) prices $4.25M offering with $4.1M warrant upside - Stock Titan

Nov 25, 2025

Nov 23, 2025

Butterfly Network, Citius Pharma Drive Biotech Momentum In After-Hours Trading - Nasdaq

Nov 23, 2025

Nov 21, 2025

Is Tempest Therapeutics Inc. stock ready for breakoutMarket Growth Report & Growth Oriented Trade Recommendations - newser.com

Nov 21, 2025

Nov 21, 2025

Will Tempest Therapeutics Inc. stock outperform growth indexesTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Tempest Therapeutics Announces New Leadership and Acquisition - MSN

Nov 20, 2025

Nov 20, 2025

Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs By Investing.com - Investing.com Australia

Nov 20, 2025

Nov 20, 2025

Check Out Tempest Therapeutics Inc (TPST)’s Trade Data Rather Than the Analysts’ Views - Setenews

Nov 20, 2025

Nov 20, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Nov 20, 2025

Nov 19, 2025

What technical signals suggest for Tempest Therapeutics Inc. stockJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Will Tempest Therapeutics Inc. stock go up soonProduct Launch & Safe Entry Trade Signal Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Tempest Therapeutics Stock Plummets Nearly 50% Amid Shareholder Dilution Fears Following CAR-T Acquisition - Markets Financial Content

Nov 19, 2025

Nov 19, 2025

Tempest gains CAR Ts for 65% of the company; stock drops - BioWorld MedTech

Nov 19, 2025

Nov 19, 2025

Why Tempest Therapeutics Inc. stock appeals to dividend seekersQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com

Nov 19, 2025

Nov 19, 2025

Tempest Therapeutics to acquire Factor Bioscience's CAR-T programs By Investing.com - Investing.com Nigeria

Nov 19, 2025

Nov 19, 2025

Is Tempest Therapeutics Inc. stock poised for growthWeekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction - MSN

Nov 19, 2025

Nov 19, 2025

Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs - Investing.com India

Nov 19, 2025

Nov 19, 2025

Tempest Therapeutics stock plunges after all-stock acquisition By Investing.com - Investing.com South Africa

Nov 19, 2025

Nov 19, 2025

Why Tempest Therapeutics (TPST) Stock Is Down 45% Today - Benzinga

Nov 19, 2025